Published in BMC Med on January 04, 2012
Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol (2013) 1.54
Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa. PLoS One (2013) 1.02
To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open (2015) 0.94
Focusing brain therapeutic interventions in space and time for Parkinson's disease. Curr Biol (2014) 0.93
Clinical translation of human neural stem cells. Stem Cell Res Ther (2013) 0.87
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? J Comp Neurol (2014) 0.86
Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease. Stem Cells (2014) 0.86
Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson's disease. Neural Regen Res (2016) 0.84
The pharmacology of regenerative medicine. Pharmacol Rev (2013) 0.83
Regenerative cellular therapies for neurologic diseases. Brain Res (2015) 0.82
Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research. PLoS One (2012) 0.80
Influence of oxygen tension on dopaminergic differentiation of human fetal stem cells of midbrain and forebrain origin. PLoS One (2014) 0.79
Stem cell-based approach for the treatment of Parkinson's disease. Med J Islam Repub Iran (2015) 0.79
Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies. Aging Dis (2015) 0.79
Neurogenic potential of hESC-derived human radial glia is amplified by human fetal cells. Stem Cell Res (2013) 0.77
For whom the bell tolls: Neurocognitive individual differences in the acute stress-reduction effects of an attention bias modification game for anxiety. Behav Res Ther (2015) 0.77
A brief perspective on neural cell therapy. Mol Cell Ther (2014) 0.75
Mobile application for diabetes self-management in China: Do they fit for older adults? Int J Med Inform (2017) 0.75
BMC Medicine: a decade of open access medical research. BMC Med (2014) 0.75
A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects. Front Aging Neurosci (2016) 0.75
Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement. Mol Neurobiol (2016) 0.75
Regenerative Medicine for the Aging Brain. Enliven J Stem Cell Res Regen Med (2015) 0.75
Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats. Rejuvenation Res (2015) 0.75
Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases. Front Mol Biosci (2016) 0.75
Maternal adversities during pregnancy and cord blood oxytocin receptor (OXTR) DNA methylation. Soc Cogn Affect Neurosci (2016) 0.75
Clinical profile of Parkinson's disease in the Gumei community of Minhang district, Shanghai. Clinics (Sao Paulo) (2014) 0.75
Cytoprotection against Hypoxic and/or MPP⁺ Injury: Effect of δ-Opioid Receptor Activation on Caspase 3. Int J Mol Sci (2016) 0.75
Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model. Sci Rep (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med (2006) 7.21
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med (2008) 6.86
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature (2002) 6.51
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature (2011) 6.21
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol (2000) 6.06
Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A (2011) 4.81
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain (2005) 3.61
FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell (1998) 3.33
Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med (2004) 2.98
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A (2010) 2.85
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest (2004) 2.39
Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest (2005) 2.25
Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells (2007) 2.22
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res (2009) 2.16
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (2006) 2.07
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain (2005) 2.06
Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells (2004) 2.05
Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol (1997) 1.98
Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.97
Cell therapy in Parkinson's disease. NeuroRx (2004) 1.93
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med (2010) 1.78
Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci (2002) 1.74
Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells (2010) 1.74
Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett (2001) 1.48
Therapeutic cloning in individual parkinsonian mice. Nat Med (2008) 1.46
Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol (2003) 1.44
Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett (2004) 1.42
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci (2007) 1.42
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis (2010) 1.41
Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells (2006) 1.40
Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci (2001) 1.34
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med (2009) 1.20
Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev (2010) 1.15
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord (2011) 1.14
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat Med (1995) 1.14
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol (2001) 1.09
Assessing fetal nerve cell grafts in Parkinson's disease. Nat Med (2008) 1.04
Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain (2008) 0.97
Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp Cell Res (2006) 0.92
Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? BMC Med (2010) 0.91
Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp Brain Res (1995) 0.83
Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. Neuroscience (2010) 0.82
Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease. BMC Med (2011) 0.78
Serotonin neurons grafted to the adult rat hippocampus. I. Time course of growth as studied by immunohistochemistry and biochemistry. Brain Res (1988) 0.76
Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A (2003) 5.09
Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A (2011) 4.81
Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells (2005) 2.88
Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci (2009) 2.74
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci (2008) 2.51
Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron (2006) 2.38
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep (2012) 2.31
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain (2005) 2.06
Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke (2007) 1.98
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci (2006) 1.91
Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia (2009) 1.86
Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol (2003) 1.80
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med (2010) 1.78
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci (2002) 1.74
Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord (2010) 1.47
Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging (2006) 1.46
Stroke-induced neurogenesis in aged brain. Stroke (2005) 1.38
Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain. J Neurosci (2009) 1.37
Inflammation regulates functional integration of neurons born in adult brain. J Neurosci (2008) 1.35
Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells (2012) 1.34
Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol Aging (2005) 1.31
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29
MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain. Mol Cell Neurosci (2008) 1.29
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J (2013) 1.28
Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab (2010) 1.24
Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol (2009) 1.23
Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke (2006) 1.18
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord (2011) 1.14
Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle (2011) 1.12
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11
Ultrastructural and antigenic properties of neural stem cells and their progeny in adult rat subventricular zone. Glia (2009) 1.11
Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci U S A (2002) 1.11
Regulation of stroke-induced neurogenesis in adult brain--recent scientific progress. Cereb Cortex (2006) 1.10
Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener Dis (2012) 1.10
Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J Neurosci Res (2006) 1.10
Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain (2013) 1.09
Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation. Eur J Neurosci (2006) 1.07
Caspase-mediated death of newly formed neurons in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci (2002) 1.07
Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS One (2011) 1.06
Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice. J Neurosci (2009) 1.05
Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J Cereb Blood Flow Metab (2008) 1.05
TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain. Exp Neurol (2005) 1.03
Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res (2002) 1.03
Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus. Neurobiol Dis (2004) 1.02
Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis (2012) 1.02
Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci Transl Med (2012) 1.02
Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival. Neurobiol Dis (2003) 0.98
Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. J Parkinsons Dis (2011) 0.95
Embryonic stem cell-derived neural stem cells fuse with microglia and mature neurons. Stem Cells (2012) 0.94
Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord (2003) 0.94
Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury. Exp Neurol (2005) 0.93
Functional integration of new hippocampal neurons following insults to the adult brain is determined by characteristics of pathological environment. Exp Neurol (2011) 0.90
Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail-Pinch. Eur J Neurosci (1989) 0.90
Meteorin is a chemokinetic factor in neuroblast migration and promotes stroke-induced striatal neurogenesis. J Cereb Blood Flow Metab (2011) 0.89
Intraventricular infusion of TrkB-Fc fusion protein promotes ischemia-induced neurogenesis in adult rat dentate gyrus. Stroke (2003) 0.89
Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo. Exp Neurol (2011) 0.89
Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur J Neurosci (2005) 0.89
Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov Disord (2008) 0.88
Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol Dis (2003) 0.88
Suppression of limbic motor seizures by electrical stimulation in thalamic reticular nucleus. Exp Neurol (2003) 0.86
Cell replacement therapy: helping the brain to repair itself. NeuroRx (2004) 0.85
Pax6 promotes neurogenesis in human neural stem cells. Mol Cell Neurosci (2008) 0.85
Altered synaptic properties during integration of adult-born hippocampal neurons following a seizure insult. PLoS One (2012) 0.85
Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9. Nat Commun (2013) 0.85
Dopaminergic neurons for Parkinson's therapy. Nat Biotechnol (2012) 0.84
Suppression of insult-induced neurogenesis in adult rat brain by brain-derived neurotrophic factor. Exp Neurol (2002) 0.84
Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats. Neurobiol Dis (2002) 0.83
Translating research into therapies. Cell (2012) 0.81
Stem cell repair of striatal ischemia. Prog Brain Res (2012) 0.80
Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke. Eur J Neurosci (2003) 0.80
Prostaglandin E2 and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: no impact on survival of seizure-generated neurons. Neurobiol Dis (2006) 0.79
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor. Brain Res Bull (2005) 0.79
Selective depletion of Mac-1-expressing microglia in rat subventricular zone does not alter neurogenic response early after stroke. Exp Neurol (2011) 0.78
FoxJ1-expressing cells contribute to neurogenesis in forebrain of adult rats: evidence from in vivo electroporation combined with piggyBac transposon. Exp Cell Res (2013) 0.78
Estimating the value of novel interventions for Parkinson's disease: an early decision-making model with application to dopamine cell replacement. Parkinsonism Relat Disord (2006) 0.78
Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke. J Neurosci (2012) 0.78
Human fetal striatum-derived neural stem (NS) cells differentiate to mature neurons in vitro and in vivo. Curr Stem Cell Res Ther (2014) 0.77
Functional properties of the human ventral mesencephalic neural stem cell line hVM1. Exp Neurol (2010) 0.75
Societal value of stem cell therapy in stroke--a modeling study. Cerebrovasc Dis (2012) 0.75
EFFECTS OF HIBERNATION OR CRYOPRESERVATION ON THE SURVIVAL AND INTEGRATION OF STRIATAL GRAFTS PLACED IN THE IBOTENATE-LESIONED RAT CAUDATE-PUTAMEN. Cell Transplant (1995) 0.75
EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR IN AND AROUND INTRASTRIATAL EMBRYONIC MESENCEPHALIC GRAFTS. Cell Transplant (1993) 0.75